Skip to main content

Market Overview

Clovis Oncology, Inc. (NASDAQ: CLVS)

5.74 -0.10 (-1.71%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/05/21HC Wainwright & Co.MaintainsBuy12.0
11/06/20SVB LeerinkMaintainsUnderperform3.0
11/06/20HC Wainwright & Co.MaintainsBuy15.0
5/22/20HC Wainwright & Co.ReiteratesBuy29.0
5/20/20SVB LeerinkMaintainsUnderperform4.0
5/18/20HC Wainwright & Co.MaintainsBuy33.0
5/06/20HC Wainwright & Co.ReiteratesBuy29.0
4/27/20SVB LeerinkDowngradesUnderperform5.0
4/09/20B of A SecuritiesDowngradesUnderperform6.0
1/23/20B of A SecuritiesMaintainsNeutral10.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter